Literature DB >> 22244149

Stalled Polη at its cognate substrate initiates an alternative translesion synthesis pathway via interaction with REV1.

Wakana Ito1, Masayuki Yokoi, Nobutaka Sakayoshi, Yasutaka Sakurai, Jun-Ichi Akagi, Hiroshi Mitani, Fumio Hanaoka.   

Abstract

DNA polymerase η (Polη), whose gene mutation is responsible for the inherited disorder xeroderma pigmentosum variant (XP-V), carries out accurate and efficient translesion synthesis (TLS) across cyclobutane pyrimidine dimer (CPD). As Polη interacts with REV1, and REV1 interacts with other TLS polymerases including Polι, Polκ and Polζ, Polη may play a role in recruitment of these TLS polymerases at lesion site. But it is unclear whether UV sensitivity of XP-V patients is caused not only by defect of Polη activity but also by dysfunction of network between Polη and other TLS polymerases. Here, we examined whether the TLS polymerase network via Polη is important for replicative bypass of CPDs and DNA damage tolerance induced by UV in mouse cells. We observed that UV sensitivity of Polη-deficient mouse cells was moderately rescued by the expression of a catalytically inactive Polη. Moreover, this recovery of cellular UV sensitivity was mediated by the interaction between Polη and REV1. However, expression of the inactive mutant Polη was not able to suppress the incidence of UV-induced mutation observed in Polη-deficient cells. We propose the model that REV1 and Polκ are involved in DNA damage tolerance via Polη-REV1 interaction when Polη fails to bypass its cognate substrates.
© 2012 The Authors. Journal compilation © 2012 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22244149     DOI: 10.1111/j.1365-2443.2011.01576.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  8 in total

1.  Y-family DNA polymerase-independent gap-filling translesion synthesis across aristolochic acid-derived adenine adducts in mouse cells.

Authors:  Keiji Hashimoto; Radha Bonala; Francis Johnson; Arthur P Grollman; Masaaki Moriya
Journal:  DNA Repair (Amst)       Date:  2016-07-29

2.  Structural insights into the assembly of human translesion polymerase complexes.

Authors:  Wei Xie; Xuan Yang; Min Xu; Tao Jiang
Journal:  Protein Cell       Date:  2012-11-10       Impact factor: 14.870

3.  NMR structure and dynamics of the C-terminal domain from human Rev1 and its complex with Rev1 interacting region of DNA polymerase η.

Authors:  Alexandra Pozhidaeva; Yulia Pustovalova; Sanjay D'Souza; Irina Bezsonova; Graham C Walker; Dmitry M Korzhnev
Journal:  Biochemistry       Date:  2012-06-28       Impact factor: 3.162

4.  Rev1 promotes replication through UV lesions in conjunction with DNA polymerases η, ι, and κ but not DNA polymerase ζ.

Authors:  Jung-Hoon Yoon; Jeseong Park; Juan Conde; Maki Wakamiya; Louise Prakash; Satya Prakash
Journal:  Genes Dev       Date:  2015-12-15       Impact factor: 11.361

Review 5.  Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?

Authors:  Kinrin Yamanaka; Nimrat Chatterjee; Michael T Hemann; Graham C Walker
Journal:  PLoS Genet       Date:  2017-08-17       Impact factor: 5.917

6.  RNA-splicing factor SART3 regulates translesion DNA synthesis.

Authors:  Min Huang; Bo Zhou; Juanjuan Gong; Lingyu Xing; Xiaolu Ma; Fengli Wang; Wei Wu; Hongyan Shen; Chenyi Sun; Xuefei Zhu; Yeran Yang; Yazhou Sun; Yang Liu; Tie-Shan Tang; Caixia Guo
Journal:  Nucleic Acids Res       Date:  2018-05-18       Impact factor: 16.971

7.  A non-catalytic role of DNA polymerase η in recruiting Rad18 and promoting PCNA monoubiquitination at stalled replication forks.

Authors:  Michael Durando; Satoshi Tateishi; Cyrus Vaziri
Journal:  Nucleic Acids Res       Date:  2013-01-23       Impact factor: 16.971

8.  Genetic and physical interactions between Polη and Rev1 in response to UV-induced DNA damage in mammalian cells.

Authors:  Tonghui Bi; Xiaohong Niu; Chunping Qin; Wei Xiao
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.